Correspondence 0001193125-24-014033 from Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc.
Date: Jan. 24, 2024 · CIK: 0000882361 · Accession: 0001193125-24-014033
AI Filing Summary & Sentiment
File numbers found in text: 333-275870
Letter
Aptose Biosciences, Inc.
251 Consumers Road, Suite 1105
Toronto, Ontario, Canada M2J 4R3
January 24, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C.
Attention: Jason Drory
Re: Aptose Biosciences Inc. – Registration Statement on Form S-1 (File No. 333-275870)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-275870), as amended (the “Registration Statement”), of Aptose Biosciences Inc. We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on January 25, 2024, or as soon thereafter as is reasonably practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Dan Miller at (604) 630-5199.
Very truly yours,
Aptose Biosciences Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Aptose Biosciences, Inc. 251 Consumers Road, Suite 1105 Toronto, Ontario, Canada M2J 4R3 January 24, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Jason Drory Re: Aptose Biosciences Inc. – Registration Statement on Form S-1 (File No. 333-275870) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-275870), as amended (the “Registration Statement”), of Aptose Biosciences Inc. We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on January 25, 2024, or as soon thereafter as is reasonably practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Dan Miller at (604) 630-5199. Very truly yours, Aptose Biosciences Inc. By: /s/ William G. Rice Name: William G. Rice Title: Chief Executive Officer